Ken Griffin Akoya Biosciences, Inc. Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Akoya Biosciences, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 24,100 shares of AKYA stock, worth $52,779. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,100
Previous 6,600
265.15%
Holding current value
$52,779
Previous $15,000
333.33%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding AKYA
# of Institutions
58Shares Held
11.9MCall Options Held
24.1KPut Options Held
0-
Blue Water Life Science Advisors, LP Larkspur, CA4.7MShares$10.3 Million11.23% of portfolio
-
Black Rock Inc. New York, NY1.5MShares$3.29 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.48MShares$3.25 Million0.0% of portfolio
-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX790KShares$1.73 Million3.97% of portfolio
-
Geode Capital Management, LLC Boston, MA562KShares$1.23 Million0.0% of portfolio
About Akoya Biosciences, Inc.
- Ticker AKYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,892,300
- Market Cap $83M
- Description
- Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...